Cargando…
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
Relapse after conventional chemotherapy remains a major problem in patients with myeloid malignancies such as acute myeloid leukemia (AML), and the major cause of death after diagnosis of AML is from relapsed disease. The only potentially curative treatment option currently available is allogeneic h...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218049/ https://www.ncbi.nlm.nih.gov/pubmed/32435621 http://dx.doi.org/10.3389/fonc.2020.00697 |